Efficacy and Safety of Evenamide, a Glutamate Modulator, Added to a Second-Generation Antipsychotic in Inadequately/Poorly Responding Patients with Chronic Schizophrenia: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3, International Clinical Trial
NEUROPHARMACOLOGY（2025）
Key words
Schizophrenia,Evenamide,Glutamate modulation,Add-on treatment,Randomized double-blind placebo-controlled,clinical trial,Inadequate response,Antipsychotics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined